共 38 条
- [1] Hewitt R., Watson P., Defining biobank, Biopreserv Biobank, 11, pp. 309-315, (2013)
- [2] Dawber T.R., Kannel W.B., The Framingham study, an epidemiologic approach to coronary heart diseas, Circulation, 34, pp. 553-555, (1966)
- [3] Kang B., Park J., Cho S., Lee M., Kim N., Min H., Current status, challenges, policies, and bioethics of biobanks, Genomics Inform, 11, pp. 211-217, (2013)
- [4] Woodbridge M., Fagiolo G., O'Regan D.P., MRIdb: medical image management for biobank research, J Digit Imaging, 26, pp. 886-890, (2013)
- [5] Petersen S.E., Matthews P.M., Bamberg F., Et al., Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank—rationale, challenges and approaches, J Cardiovasc Magn Reson, 15, (2013)
- [6] Starkbaum J., Gottweis H., Gottweis U., Et al., Public perceptions of cohort studies and biobanks in Germany, Biopreserv Biobank, 12, pp. 121-130, (2014)
- [7] Prescott J.W., Quantitative imaging biomarkers: the application of advanced image processing and analysis to clinical and preclinical decision making, J Digit Imaging, 26, pp. 97-108, (2013)
- [8] Kessler L.G., Barnhart H.X., Buckler A.J., QIBA Terminology Working Group, Et al., The emerging science of quantitative imaging biomarkers terminology and definitions for scientific studies and regulatory submissions, Stat Methods Med Res, 24, 1, pp. 9-26, (2014)
- [9] Raunig D.L., McShane L.M., Pennello G., QIBA Technical Performance Working Group, Et al., Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment, Stat Methods Med Res, 24, 1, pp. 27-67, (2014)
- [10] Olson J.E., Bielinski S.J., Ryu E., Winkler E.M., Takahashi P.Y., Pathak J., Biobanks and personalized medicine, Clin Genet, 86, pp. 50-55, (2014)